<DOC>
	<DOCNO>NCT00148512</DOCNO>
	<brief_summary>The primary objective exploratory study investigate efficacy safety tesofensine daily dos ( 0.125 mg 1.0 mg ) comparison placebo , 14-week treatment period levodopa treat Parkinson patient motor fluctuation .</brief_summary>
	<brief_title>A Randomized , Double-blind , Placebo-controlled , Five Parallel Groups Efficacy Safety Study NS 2330 ( Tesofensine ) ( 0.125 mg , 0.25 mg , 0.5 mg 1.0 mg ) Administered Orally Once Daily Over 14 Weeks Levodopa Treated Parkinson Patients With Motor Fluctuations</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , five parallel group efficacy safety exploratory tesofensine versus placebo levodopa treat Parkinson patient motor fluctuation . Patients treat either one 4 dos tesofensine ( 0.125mg , 0.25mg , 0.50 mg 1.0 mg ) placebo , daily , 14 week . The two co-primary efficacy endpoint change off-time change Unified Parkinson Disease Rating Scale ( UPDRS ) II+III total score Study Hypothesis : The null hypothesis difference placebo tesofensine . The alternative hypothesis treatment tesofensine superior treatment placebo . Comparison ( ) : For primary comparison tesofensine placebo , change percentage off-time waking hour base report patient 's diary ( complete day -3 day-2 prior study visit ) change UPDRS II+III base UPDRS II average period UPDRS III evaluate period study visit .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Main inclusion criterion : Male female patient idiopathic Parkinson Disease ( PD ) diagnose least 2 year . Patient age 40 year time diagnosis PD old 80 year screen visit . Modified Hoehn Yahr stage II III `` '' time . Treatment Levodopa optimise dose , 4 8 time per day , dose stable least 4 week prior screen visit . Motor fluctuation , 2.0 6.0 cumulative hour `` '' time every day wake hour , document patient 's diary complete 2 consecutive day baseline visit . Main exclusion criterion : Neuropsychiatric exclusion : Nonidiopathic PD , dementia ( Mini Mental State Exam &lt; 26 ) , history psychosis , history current Axis I Axis II mental disorder accord DSMIV , etc Other medical exclusion , like ECG abnormality , hypotension and/or symptomatic orthostatic hypotension , abnormal laboratory parameter ( e.g . severe renal impairment ) , etc Pharmacological exclusion , e.g . selegiline within 8 week prior screen visit , regular use antidepressant drug , medication central dopaminergic antagonist activity , etc</criteria>
	<gender>All</gender>
	<minimum_age>42 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>